Home Hologic, Inc. (HOLX) Upgraded at Zacks Investment Research
 

Keywords :   


Hologic, Inc. (HOLX) Upgraded at Zacks Investment Research

2015-12-21 05:46:43| Biotech - Topix.net

The firm currently has a $43.00 target price on the stock. Zacks Investment Research 's price target would indicate a potential upside of 11.46% from the company's previous close.

Tags: research investment upgraded zacks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
07.11Ahlstroms Climate Targets Validated by SBTi
07.11Mativ Reports Third Quarter Results
07.11Lawsuit over FDA's regulatory approval process for carbadox dismissed
07.11Hurricane Rafael Graphics
07.11Hurricane Rafael Forecast Discussion Number 16
07.11Hurricane Rafael Wind Speed Probabilities Number 16
07.11Hurricane Rafael Forecast Advisory Number 16
07.11Hurricane Rafael Public Advisory Number 16
More »